Abstract
Sexual dimorphism creates different biological and cellular activities and selective regulation mechanisms in males and females, thus generating differential responses in health and disease. In this scenario, the sex itself is a source of physiologic metabolic disparities that depend on constitutive genetic and epigenetic features that characterize in a specific manner one sex or the other. This has as a direct consequence a huge impact on the metabolic routes that drive the phenotype of an individual. The impact of sex is being clearly recognized also in disease, whereas male and females are more prone to the development of some disorders, or have selective responses to drugs and therapeutic treatments. Actually, very less is known regarding the probable differences guided by sex in the context of inherited metabolic disorders, owing to the scarce consideration of sex in such restricted field, accompanied by an intrinsic bias connected with the rarity of such diseases. Metabolomics technologies have been ultimately developed and adopted for being excellent tools for the investigation of metabolic mechanisms, for marker discovery or monitoring, and for supporting diagnostic procedures of metabolic disorders. Hence, metabolomic approaches can excellently embrace the discovery of sex differences, especially when associated to the outcome or the management of certain inborn errors of the metabolism.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Albersen M, Bonthuis M, de Roos NM et al (2010) Whole body composition analysis by the BodPod air-displacement plethysmography method in children with phenylketonuria shows a higher body fat percentage. J Inherit Metab Dis 33:283–288. https://doi.org/10.1007/s10545-010-9149-8
Allen J, McCauley J, Waters D et al (1995) Resting energy expenditure in children with phenylketonuria. Am J Clin Nutr 62:797–801. https://doi.org/10.1093/ajcn/62.4.797
Allen JR, Baur LA, Waters DL et al (1996) Body protein in prepubertal children with phenylketonuria. Eur J Clin Nutr 50:178–186
Beale DJ, Pinu FR, Kouremenos KA et al (2018) Review of recent developments in GC–MS approaches to metabolomics-based research. Metabolomics
Bell SM, Wendt DJ, Zhang Y et al (2017) Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria. PLoS One 12:e0173269. https://doi.org/10.1371/journal.pone.0173269
Braun AE, Mitchel OR, Gonzalez TL et al (2022) Sex at the interface: the origin and impact of sex differences in the developing human placenta. Biol Sex Differ 13:50. https://doi.org/10.1186/s13293-022-00459-7
Brennan L, Gibbons H (2020) Sex matters: a focus on the impact of biological sex on metabolomic profiles and dietary interventions. Proc Nutr Soc 79:205–209. https://doi.org/10.1017/S002966511900106X
Campesi I, Occhioni S, Tonolo G et al (2016) Ageing/menopausal status in healthy women and ageing in healthy men differently affect cardiometabolic parameters. Int J Med Sci 13:124–132. https://doi.org/10.7150/ijms.14163
Campesi I, Milella L, Palermo M et al (2020) Cigarette smoking affects the differences between male and female phenotypes. Am J Transl Res 12:2998–3010
Campesi I, Franconi F, Montella A et al (2021a) Human umbilical cord: information mine in sex-specific medicine. Life 11:52. https://doi.org/10.3390/life11010052
Campesi I, Montella A, Seghieri G, Franconi F (2021b) The person’s care requires a sex and gender approach. J Clin Med 10:4770. https://doi.org/10.3390/jcm10204770
Campesi I, Montella A, Sotgiu G et al (2021c) Combined oral contraceptives modify the effect of smoking on inflammatory cellular indexes and endothelial function in healthy subjects. Eur J Pharmacol 891:173762. https://doi.org/10.1016/j.ejphar.2020.173762
Campesi I, Montella A, Sotgiu G et al (2022) Smoking and combined oral contraceptives should be considered as an independent variable in sex and gender-oriented studies. Toxicol Appl Pharmacol 457:116321. https://doi.org/10.1016/j.taap.2022.116321
Caterino M, Ruoppolo M, Villani GRD et al (2020) Influence of sex on urinary organic acids: a cross-sectional study in children. Int J Mol Sci 21:582. https://doi.org/10.3390/ijms21020582
Caterino M, Ruoppolo M, Costanzo M et al (2021) Sex affects human premature neonates’ blood metabolome according to gestational age, parenteral nutrition, and caffeine treatment. Metabolites 11:158. https://doi.org/10.3390/metabo11030158
Chandler RJ, Venditti CP (2019) Gene therapy for methylmalonic acidemia: past, present, and future. Hum Gene Ther 30:1236–1244. https://doi.org/10.1089/hum.2019.113
Clegg DJ, Mauvais-Jarvis F (2018) An integrated view of sex differences in metabolic physiology and disease. Mol Metab 15:1–2. https://doi.org/10.1016/j.molmet.2018.06.011
Costanzo M, Caterino M (2023) Targeted lipidomics data of COVID-19 patients. Data Br 48:109089. https://doi.org/10.1016/j.dib.2023.109089
Costanzo M, Caterino M, Cevenini A et al (2020a) Data independent acquisition mass spectrometry for proteomic advances into isolated methylmalonic acidemia. In: NATO science for peace and security series A: chemistry and biology. Springer Science and Business Media B.V, pp 221–223
Costanzo M, Caterino M, Cevenini A et al (2020b) Dataset of a comparative proteomics experiment in a methylmalonyl-CoA mutase knockout HEK 293 cell model. Data Br 33:106453. https://doi.org/10.1016/j.dib.2020.106453
Costanzo M, Fiocchetti M, Ascenzi P et al (2021) Proteomic and bioinformatic investigation of altered pathways in neuroglobin-deficient breast cancer cells. Molecules 26:2397. https://doi.org/10.3390/molecules26082397
Costanzo M, Caterino M, Ruoppolo M (2022a) Targeted metabolomics. In: Metabolomics perspectives. Elsevier, pp 219–236
Costanzo M, Caterino M, Salvatori I et al (2022b) Proteome data of neuroblastoma cells overexpressing neuroglobin. Data Br 41:107843. https://doi.org/10.1016/j.dib.2022.107843
Costanzo M, Caterino M, Sotgiu G et al (2022c) Sex differences in the human metabolome. Biol Sex Differ 13:30. https://doi.org/10.1186/s13293-022-00440-4
Couce ML, Guler I, Anca-Couce A et al (2015) New insights in growth of phenylketonuric patients. Eur J Pediatr 174:651–659. https://doi.org/10.1007/s00431-014-2446-8
Critelli K, McKiernan P, Vockley J et al (2018) Liver transplantation for propionic acidemia and methylmalonic acidemia: perioperative management and clinical outcomes. Liver Transpl 24:1260–1270. https://doi.org/10.1002/lt.25304
Dane AP, Cunningham SC, Graf NS, Alexander IE (2009) Sexually dimorphic patterns of episomal rAAV genome persistence in the adult mouse liver and correlation with hepatocellular proliferation. Mol Ther 17:1548–1554. https://doi.org/10.1038/mt.2009.139
Davidoff AM, Ng CYC, Zhou J et al (2003) Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway. Blood 102:480–488. https://doi.org/10.1182/blood-2002-09-2889
de Baulny HO, Abadie V, Feillet F, de Parscau L (2007) Management of phenylketonuria and hyperphenylalaninemia. J Nutr 137:1561S–1563S. https://doi.org/10.1093/jn/137.6.1561S
Di Minno A, Gelzo M, Caterino M et al (2022) Challenges in metabolomics-based tests, biomarkers revealed by metabolomic analysis, and the promise of the application of metabolomics in precision medicine. Int J Mol Sci 23:5213. https://doi.org/10.3390/ijms23095213
Dobbelaere D, Michaud L, Debrabander A et al (2003) Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria. J Inherit Metab Dis 26:1–11. https://doi.org/10.1023/A:1024063726046
Doulgeraki A, Skarpalezou A, Theodosiadou A et al (2014) Body composition profile of young patients with phenylketonuria and mild hyperphenylalaninemia. Int J Endocrinol Metab 12. https://doi.org/10.5812/ijem.16061
Elhawary NA, AlJahdali IA, Abumansour IS et al (2022) Genetic etiology and clinical challenges of phenylketonuria. Hum Genomics 16:22. https://doi.org/10.1186/s40246-022-00398-9
Firman SJ, Ramachandran R, Whelan K et al (2022) Protein status in phenylketonuria: a scoping review. Clin Nutr 41:894–922. https://doi.org/10.1016/j.clnu.2022.02.010
Franconi F, Rosano G, Campesi I (2015) Need for gender-specific pre-analytical testing: the dark side of the moon in laboratory testing. Int J Cardiol 179:514–535. https://doi.org/10.1016/j.ijcard.2014.11.019
Gonzalez Melo M, Fontana A, Viertl D et al (2021a) A knock-in rat model unravels acute and chronic renal toxicity in glutaric aciduria type I. Mol Genet Metab. https://doi.org/10.1016/j.ymgme.2021.10.003
Gonzalez Melo M, Remacle N, Cudré-Cung H-P et al (2021b) The first knock-in rat model for glutaric aciduria type I allows further insights into pathophysiology in brain and periphery. Mol Genet Metab 133:157–181. https://doi.org/10.1016/j.ymgme.2021.03.017
Guenzel AJ, Hillestad ML, Matern D, Barry MA (2014) Effects of adeno-associated virus serotype and tissue-specific expression on circulating biomarkers of propionic acidemia. Hum Gene Ther 25:837–843. https://doi.org/10.1089/hum.2014.012
Guenzel AJ, Collard R, Kraus JP et al (2015) Long-term sex-biased correction of circulating propionic acidemia disease markers by adeno-associated virus vectors. Hum Gene Ther 26:153–160. https://doi.org/10.1089/hum.2014.126
Hanley WB (2011) Non-PKU mild hyperphenylalaninemia (MHP) – the dilemma. Mol Genet Metab 104:23–26. https://doi.org/10.1016/j.ymgme.2011.05.007
Huang CS, Sadre-Bazzaz K, Shen Y et al (2010) Crystal structure of the α6β6 holoenzyme of propionyl-coenzyme A carboxylase. Nature 466:1001–1005. https://doi.org/10.1038/nature09302
Huemer M, Huemer C, Möslinger D et al (2007) Growth and body composition in children with classical phenylketonuria: results in 34 patients and review of the literature. J Inherit Metab Dis 30:694–699. https://doi.org/10.1007/s10545-007-0549-3
Jiang L, Park J-S, Yin L et al (2020) Dual mRNA therapy restores metabolic function in long-term studies in mice with propionic acidemia. Nat Commun 11:5339. https://doi.org/10.1038/s41467-020-19156-3
Johnson CH, Gonzalez FJ (2012) Challenges and opportunities of metabolomics. J Cell Physiol
Joyce AR, Palsson B (2006) The model organism as a system: integrating “omics” data sets. Nat Rev Mol Cell Biol
Kautzky-Willer A, Handisurya A (2009) Metabolic diseases and associated complications: sex and gender matter! Eur J Clin Investig 39:631–648. https://doi.org/10.1111/j.1365-2362.2009.02161.x
Knerr I, Weinhold N, Vockley J, Gibson KM (2012) Advances and challenges in the treatment of branched-chain amino/keto acid metabolic defects. J Inherit Metab Dis 35:29–40. https://doi.org/10.1007/s10545-010-9269-1
Kwiatkowski K, Coe K, Bailar JC, Swanson GM (2013) Inclusion of minorities and women in cancer clinical trials, a decade later: have we improved? Cancer 119:2956–2963. https://doi.org/10.1002/cncr.28168
Lichter-Konecki U, Vockley J (2019) Phenylketonuria: current treatments and future developments. Drugs 79:495–500. https://doi.org/10.1007/s40265-019-01079-z
Link JC, Chen X, Arnold AP, Reue K (2013) Metabolic impact of sex chromosomes. Adipocytes 2:74–79. https://doi.org/10.4161/adip.23320
Maestro S, Weber ND, Zabaleta N et al (2021) Novel vectors and approaches for gene therapy in liver diseases. JHEP Rep 3:100300. https://doi.org/10.1016/j.jhepr.2021.100300
Manganelli V, Salvatori I, Costanzo M et al (2021) Overexpression of neuroglobin promotes energy metabolism and autophagy induction in human neuroblastoma SH-SY5Y cells. Cell 10:3394. https://doi.org/10.3390/cells10123394
Mauvais-Jarvis F, Arnold AP, Reue K (2017) A guide for the design of pre-clinical studies on sex differences in metabolism. Cell Metab 25:1216–1230. https://doi.org/10.1016/j.cmet.2017.04.033
Mauvais-Jarvis F, Berthold HK, Campesi I et al (2021) Sex- and gender-based pharmacological response to drugs. Pharmacol Rev 73:730–762. https://doi.org/10.1124/pharmrev.120.000206
McBurnie MA, Kronmal RA, Schuett VE et al (1991) Physical growth of children treated for phenylketonuria. Ann Hum Biol 18:357–368. https://doi.org/10.1080/03014469100001662
Mitani AA, Haneuse S (2020) Small data challenges of studying rare diseases. JAMA Netw Open 3:e201965. https://doi.org/10.1001/jamanetworkopen.2020.1965
Mittelstrass K, Ried JS, Yu Z et al (2011) Discovery of sexual dimorphisms in metabolic and genetic biomarkers. PLoS Genet. https://doi.org/10.1371/journal.pgen.1002215
Nicholson JK, Lindon JC (2008) Systems biology: metabonomics. Nature
Pañeda A, Vanrell L, Mauleon I et al (2009) Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both genders. Hum Gene Ther 20:908–917. https://doi.org/10.1089/hum.2009.031
Prakash VS, Mansukhani NA, Helenowski IB et al (2018) Sex bias in interventional clinical trials. J Women’s Health 27:1342–1348. https://doi.org/10.1089/jwh.2017.6873
Rich-Edwards JW, Kaiser UB, Chen GL et al (2018) Sex and gender differences research design for basic, clinical, and population studies: essentials for investigators. Endocr Rev 39:424–439. https://doi.org/10.1210/er.2017-00246
Rocha JC, van Spronsen FJ, Almeida MF et al (2013) Early dietary treated patients with phenylketonuria can achieve normal growth and body composition. Mol Genet Metab 110:S40–S43. https://doi.org/10.1016/j.ymgme.2013.10.009
Roviello GN, Roviello G, Musumeci D et al (2014) Synthesis and supramolecular assembly of 1,3-bis(1′-uracilyl)-2- propanone. RSC Adv 4:28691–28698. https://doi.org/10.1039/c4ra03713h
Ruoppolo M, Campesi I, Scolamiero E et al (2014) Serum metabolomic profiles suggest influence of sex and oral contraceptive use. Am J Transl Res
Ruoppolo M, Scolamiero E, Caterino M et al (2015) Female and male human babies have distinct blood metabolomic patterns. Mol BioSyst. https://doi.org/10.1039/c5mb00297d
Ruoppolo M, Caterino M, Albano L et al (2018) Targeted metabolomic profiling in rat tissues reveals sex differences. Sci Rep 8:4663. https://doi.org/10.1038/s41598-018-22869-7
Ruoppolo M, Malvagia S, Boenzi S et al (2022) Expanded newborn screening in Italy using tandem mass spectrometry: two years of national experience. Int J Neonatal Screen 8:47. https://doi.org/10.3390/ijns8030047
Sailer M, Elizondo G, Martin J et al (2020) Nutrient intake, body composition, and blood phenylalanine control in children with phenylketonuria compared to healthy controls. Mol Genet Metab Rep 23:100599. https://doi.org/10.1016/j.ymgmr.2020.100599
Santorelli L, Caterino M, Costanzo M (2022) Dynamic interactomics by cross-linking mass spectrometry: mapping the daily cell life in postgenomic era. Omi A J Integr Biol 26:633–649. https://doi.org/10.1089/omi.2022.0137
Schrimpe-Rutledge AC, Codreanu SG, Sherrod SD, McLean JA (2016) Untargeted metabolomics strategies – challenges and emerging directions. J Am Soc Mass Spectrom. https://doi.org/10.1007/s13361-016-1469-y
Seghieri G, Franconi F, Campesi I (2022) Why we need sex-gender medicine: the striking example of type 2 diabetes. Diabetology 3:460–469. https://doi.org/10.3390/diabetology3030034
Stotland NL (2001) Gender-based biology. Am J Psychiatry 158:161–162. https://doi.org/10.1176/appi.ajp.158.2.161
Stroup BM, Sawin EA, Murali SG et al (2017) Amino acid medical foods provide a high dietary acid load and increase urinary excretion of renal net acid, calcium, and magnesium compared with glycomacropeptide medical foods in phenylketonuria. J Nutr Metab 2017:1–12. https://doi.org/10.1155/2017/1909101
Stroup BM, Hansen KE, Krueger D et al (2018) Sex differences in body composition and bone mineral density in phenylketonuria: a cross-sectional study. Mol Genet Metab Rep 15:30–35. https://doi.org/10.1016/j.ymgmr.2018.01.004
Tarnopolsky MA, Ruby BC (2001) Sex differences in carbohydrate metabolism. Curr Opin Clin Nutr Metab Care 4:521–526. https://doi.org/10.1097/00075197-200111000-00010
Tavassoly I, Goldfarb J, Iyengar R (2018) Systems biology primer: the basic methods and approaches. Essays Biochem 62:487–500. https://doi.org/10.1042/EBC20180003
Tramunt B, Smati S, Grandgeorge N et al (2020) Sex differences in metabolic regulation and diabetes susceptibility. Diabetologia 63:453–461. https://doi.org/10.1007/s00125-019-05040-3
van Spronsen FJ, Blau N, Harding C et al (2021) Phenylketonuria. Nat Rev Dis Primers 7:36. https://doi.org/10.1038/s41572-021-00267-0
Vela-Amieva M, Alcántara-Ortigoza MA, Ibarra-González I et al (2022) Genotypic spectrum underlying tetrahydrobiopterin metabolism defects: experience in a single Mexican reference center. Front Genet 13. https://doi.org/10.3389/fgene.2022.993612
Wang C, Xu Y (2019) Mechanisms for sex differences in energy homeostasis. J Mol Endocrinol 62:R129–R143. https://doi.org/10.1530/JME-18-0165
Wishart DS (2011) Advances in metabolite identification. Bioanalysis
Wongkittichote P, Ah Mew N, Chapman KA (2017) Propionyl-CoA carboxylase – a review. Mol Genet Metab 122:145–152. https://doi.org/10.1016/j.ymgme.2017.10.002
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Campesi, I., Ruoppolo, M., Franconi, F., Caterino, M., Costanzo, M. (2023). Sex-Gender-Based Differences in Metabolic Diseases. In: Tsirka, S.E., Acosta-Martinez, M. (eds) Sex and Gender Effects in Pharmacology . Handbook of Experimental Pharmacology, vol 282. Springer, Cham. https://doi.org/10.1007/164_2023_683
Download citation
DOI: https://doi.org/10.1007/164_2023_683
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-42647-6
Online ISBN: 978-3-031-42648-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)